Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association? - Wikidata - wikimedia - TriplyDB

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

http://www.wikidata.org/entity/Q37710176

about

Elevated Levels of ADMA Are Associated with Lower DDAH2 and Higher PRMT1 in LPS-Induced Endometritis Rats.Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease

P2860

Q46265148-8034723A-6217-4903-A1B5-B48F35968C00 Q57306318-FCEA7E2D-E930-42A3-992D-043168234934

P2860

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

http://www.wikidata.org/entity/Q37710176

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

@en

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

@nl

type

label

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

@en

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

@nl

prefLabel

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

@en

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

@nl

P1433

Q37710176-3C38C5AF-C1B5-42D6-8CA5-6FDE851BEB18

P1476

Q37710176-DDA6BF88-5345-4CF3-A26B-22AB748E3E14

P2093

Q37710176-EC0E3AAD-2561-44EA-85FB-89558C3E7CCF

P275

Q37710176-115288FC-455D-4AC0-A289-D6AC2A731A8D

P2860

Q37710176-07732E7F-31DD-4361-9ABF-640C6732A442

Q37710176-0C06DB41-2353-4ECD-9CD9-B240FA8E1E01

Q37710176-0D3F14E0-7C69-4B7B-A7EA-02E580ACB0E2

Q37710176-0F50AB18-A195-4A90-B992-BC69877D908D

Q37710176-0FE3B1C0-A138-4394-A904-92C9EB84F35A

Q37710176-1088CBCC-95BA-49B4-87E5-974776DB76CA

Q37710176-12059421-7F97-4224-8B49-840F98BC82D4

Q37710176-161FF63F-05FA-4FBE-B79B-15256A527FBE

Q37710176-1656EEDC-236B-41CB-9653-164CB1AF21B5

Q37710176-167EBD2E-DDCA-4DF2-B8EB-7629488620C6

P2888

Q37710176-F2CD48E4-E87E-432A-BF2E-BF6708539156

P304

Q37710176-7A69ECFB-2EA4-4373-B223-427C3AD59423

P31

Q37710176-B47FEC0F-854B-40F8-AED5-9AD7DB5593FE

P356

Q37710176-FB77F1B4-BE12-4438-8C32-773FA5A68F57

P433

Q37710176-3709C27F-2952-4490-942F-67EAC8BF64EE

P478

Q37710176-4FAE5B86-5A33-459C-94F7-04B2B90EDBA0

P50

Q37710176-14892B46-E9ED-4C6F-BD1A-F628E3E05DD1

Q37710176-51086C1C-0407-440B-81CC-D7815FED071C

P5008

Q37710176-F4CDB8E8-172B-4B1E-A34B-DDA0A8B7D858

P577

Q37710176-60B7B1A1-F32B-492A-9FE5-8C52145717DF

P698

Q37710176-24C5DDD5-F366-4466-B33C-D1E9B5955699

P921

Q37710176-008DE51E-A2E7-44C7-A7AC-0669FCF6CB7B

Q37710176-CA0F2A97-DE63-4334-85C3-AB1AEE6C4214

P932

Q37710176-C7C1072F-C5DF-418C-B310-168A245D0262

P356

S11064-016-2111-X

P1433

Neurochemical Research

P1476

Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

@en

P2093

Krzysztof Milewski

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production

Asymmetric dimethyarginine as marker and mediator in ischemic stroke

FXR agonist INT-747 upregulates DDAH expression and enhances insulin sensitivity in high-salt fed Dahl rats

Clinical neurophysiology of hepatic encephalopathy

Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis

Oral L-arginine improves endothelial function in healthy individuals older than 70 years

Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats

Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat

Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation

Protein arginine methylation in mammals: who, what, and why

P2888

s11064-016-2111-x

P304

750-761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11064-016-2111-X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Magdalena Zielińska

P5008

P577

2016-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27885576

http://www.w3.org/2001/XMLSchema#string

P921

hepatic encephalopathy

P932

5357500

http://www.w3.org/2001/XMLSchema#string